SCYNEXIS, Inc. (SCYX) is a publicly traded Healthcare sector company. As of October 29, 2026, SCYX trades at $3.96 with a market cap of $37.81M and a P/E ratio of 16.81. SCYX moved +0.00% today. Year to date, SCYX is -22.67%; over the trailing twelve months it is -30.94%. Its 52-week range spans $3.53 to $10.48. Analyst consensus is buy with an average price target of $32.00. Rallies surfaces SCYX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for SCYX shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $3.96 |
| Market Cap | $37.81M |
| P/E Ratio | 16.81 |
| EPS | $0.29 |
| Dividend Yield | 0.00% |
| 52-Week High | $10.48 |
| 52-Week Low | $3.53 |
| Volume | 18.01K |
| Avg Volume | 0 |
| Revenue (TTM) | $19.21M |
| Net Income | $-10.23M |
| Gross Margin | 0.00% |
1 analysts cover SCYX: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $32.00.